Investor Presentation Q1 2023

112 Investor presentation First three months of 2023 Obesity market share and market growth in EMEA 120% 100% 80% 60% 40% 20% Obesity market growth and Novo Nordisk market share 0% Feb 2020 NN market share -NN Growth -Market growth (right axis) Source: IQVIA, Feb 2023, Value, MAT; EMEA: Europe, Middle East and Africa; NN: Novo Nordisk DKK billion Obesity market size and growth -85% 120% 2.8 109% 0.1 100% 84% 1.2 80% 85% 1.5 60% 40% 20% 75% EMEA ~109% 84% 0% Feb Feb Feb 2023 2022 2023 Novo Nordisk Others

View entire presentation